CARL SOLUTIONS
ResuSciTec GmbH
Trademark Registered: 2022-06-14
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79306697 |
| Registration Number | 6756309 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Timeline
| 2020-11-10 | Application Filed |
| 2021-03-18 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2021-03-18 | Status: Live/Pending |
| 2021-03-19 | Transaction Date |
| 2022-06-14 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  ResuSciTec GmbH |
| Address | Engesserstr. 4a 79108 Freiburg i.Br. XP |
| Legal Entity Type | |
| Legal Entity State | XP |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| International Codes: | 9 |
| U.S. Codes: | 021,023,026,036,038 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| International Codes: | 39 |
| U.S. Codes: | 100,105 |
| International Codes: | 41 |
| U.S. Codes: | 100,101,107 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Medical and veterinary preparations and articles; pharmaceuticals and natural remedies; diagnostic preparations for medical purposes; medicines for veterinary purposes; biological preparations for medical purposes; biological preparations for veterinary purposes; blood for medical purposes; blood components; blood substitutes; blood plasma; enzymes for veterinary purposes; enzyme preparations for medical purposes; enzyme preparations for veterinary purposes; solid oxygen for medical use; gases for medical purposes; gas mixtures for medical use; haemoglobin; cooling sprays for medical purposes; pharmaceutical preparations for veterinary use; radioactive substances for medical purposes; solidified gases for medical purposes; veterinary preparations |
| GS0411 | Training for handling scientific instruments and apparatus for research in laboratories; education services, namely, providing courses of instruction in the field of therapeutic treatments, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; training services in the field of health and safety, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; training services in the field of occupational health, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical education services in the nature of courses of instruction in the field of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; educational services in the nature of courses of instruction in the field of first aid, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; training services for medical visitors in the field of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; teaching services in the nature of courses of instruction in the surgical field, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; education services in the nature of courses of instruction in the field of medicine, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; training services in the field of first aid, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; workshops for educational purposes in the field of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2021-03-18 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-03-19 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2021-03-23 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2021-04-20 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2021-04-22 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2021-04-23 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2021-04-27 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2021-04-27 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2021-05-24 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-06-04 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-06-04 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-06-05 | 12 TEME I:Incoming Correspondence |
| LIMITATION OF GOODS RECEIVED FROM IB | 2021-06-19 | 13 LIMG M: |
| LIMITATION FROM THE IB - REQUEST EXAM REVIEW | 2021-06-29 | 14 LIME X:Correction |
| NON-FINAL ACTION WRITTEN | 2021-07-12 | 15 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2021-07-12 | 16 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-07-12 | 17 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-01-11 | 18 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-01-11 | 19 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-01-12 | 20 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2022-02-22 | 21 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2022-02-22 | 22 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2022-02-22 | 23 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2022-02-22 | 24 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-02-22 | 25 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-03-09 | 26 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2022-03-09 | 27 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2022-03-09 | 28 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2022-03-27 | 29 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2022-03-29 | 30 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-03-29 | 31 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2022-06-14 | 32 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2022-06-14 | 33 NRCC E:E-Mail |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2022-09-14 | 34 FICR P: |
| FINAL DISPOSITION PROCESSED | 2022-09-23 | 35 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2022-09-23 | 36 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2022-10-17 | 37 FINO P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 